The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.

被引：0
|
作者：
Stewart, Grant
Laird, Alexander
O'Mahony, Fiach
Eory, Lel
Lubbock, Alexander
Nanda, Jyoti
O'Donnell, Marie
Mackay, Alan
Mullen, Peter
McNeill, Alan
Riddick, Antony
Aitchison, Michael
Berney, Daniel
Bex, Axel
Overton, Ian
Harrison, David James
Powles, Tom
机构：
[1] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[2] Roslin Inst, Edinburgh, Midlothian, Scotland
[3] MRC Human Genet Unit, Edinburgh, Midlothian, Scotland
[4] Royal Marsden NHS Fdn Trust, Inst Canc Res, London, England
[5] Univ St Andrews, St Andrews, Fife, Scotland
[6] Addenbrookes Hosp, Dept Urol, Cambridge CB2 2QQ, England
[7] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
[8] St Bartholomews Hosp, London, England
[9] Netherlands Canc Inst, Amsterdam, Netherlands
[10] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
[11] Queen Mary Univ London, Barts Canc Inst, Barts Expt Canc Med Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 04期
关键词：
D O I：
10.1200/jco.2014.32.4_suppl.408
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
408
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Sunitinib and everolimus for the treatment of a patient with clear cell renal cancer
    Bodnar, Lubomir
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C7 - C8
  • [22] The safety and efficacy of pazopanib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Boleti, Ekaterini
    Sarwar, Naveed
    Jones, Robert R.
    Chowdhury, Simon
    Crabb, Simon J.
    Shamash, Jonathan
    Peters, John
    Oades, Grenville
    O'Brien, Tim S.
    Berney, Dan
    Rockall, Andrea
    Powles, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [23] Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
    Kayani, Irfan
    Avril, Norbert
    Bomanji, Jamshed
    Chowdhury, Simon
    Rockall, Andrea
    Sahdev, Anju
    Nathan, Paul
    Wilson, Peter
    Shamash, Jonathan
    Sharpe, Kevin
    Lim, Louise
    Dickson, John
    Ell, Peter
    Reynolds, Andrew
    Powles, Thomas
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 6021 - 6028
  • [24] VEGF Expression and Response to Sunitinib in Patients with Metastatic Clear Cell Renal Cell Carcinoma
    Minardi, Daniele
    Lucarini, Guendalina
    Santoni, Matteo
    Mazzucchelli, Roberta
    Burattini, Luciano
    Pistelli, Mirco
    Bianconi, Maristella
    Di Primio, Roberto
    Scartozzi, Mario
    Montironi, Rodolfo
    Cascinu, Stefano
    Muzzonigro, Giovanni
    ANTICANCER RESEARCH, 2013, 33 (11) : 5017 - 5022
  • [25] Nomogram for Predicting Resistance to Sunitinib in Patients with Metastatic Clear Cell Renal Carcinoma
    Kammerer-Jacquet, S-F
    Belaud-Rotureau, M-A
    Oger, E.
    Verhoest, G.
    Lespagnol, A.
    Edeline, J.
    Jaillard, S.
    Laguerre, B.
    Vauleon, E.
    Mosser, J.
    Bensalah, K.
    Rioux-Leclercq, N.
    LABORATORY INVESTIGATION, 2014, 94 : 238A - 238A
  • [26] Nomogram for Predicting Resistance to Sunitinib in Patients with Metastatic Clear Cell Renal Carcinoma
    Kammerer-Jacquet, S-F
    Belaud-Rotureau, M-A
    Oger, E.
    Verhoest, G.
    Lespagnol, A.
    Edeline, J.
    Jaillard, S.
    Laguerre, B.
    Vauleon, E.
    Mosser, J.
    Bensalah, K.
    Rioux-Leclercq, N.
    MODERN PATHOLOGY, 2014, 27 : 238A - 238A
  • [27] Tislelizumab combined with sunitinib in the treatment of metastatic clear cell renal cell carcinoma with renal venous tumor thrombus: A case report and literature review
    Gao, Zhixiang
    Jin, Lu
    Lv, Haijun
    Duan, Nengliang
    Zhang, Guoneng
    Ran, Yuanshuai
    Xue, Boxin
    Liu, Xiaolong
    UROLOGY CASE REPORTS, 2024, 54
  • [28] Site of metastasis in metastatic clear cell renal cell carcinoma (mccRCC) and outcome of treatment with sunitinib
    Beuselinck, B.
    Rixe, O.
    Oudard, S.
    Wolter, P.
    Ayllon, J.
    Elaidi, R.
    Schoffski, P.
    Scotte, F.
    Zucman-Rossi, J.
    Medioni, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Sunitinib in metastatic clear cell renal cancer (CCRC): A real life Chilean single institution experience.
    Orlandi, Luis J.
    Pablo Galaz, Pedro
    Melo Holloway, Robert
    Melina Linares, Belkys
    Larrain Garcia, Vicente
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [30] Immune expression profile and sunitinib benefit in metastatic clear cell renal cell carcinoma (ccRCC)
    Reig Torras, O.
    Marin-Aguilera, M.
    Jimenez, N.
    Pare, L.
    Galvan, P.
    Mallofre, C.
    Prat, A.
    Mellado Gonzalez, B.
    ANNALS OF ONCOLOGY, 2017, 28
12345